Name | Number of supported studies | Average coverage | |
---|---|---|---|
microglial cell | 10 studies | 29% ± 12% | |
mast cell | 6 studies | 24% ± 6% | |
macrophage | 6 studies | 26% ± 7% | |
endothelial cell | 5 studies | 26% ± 5% | |
fibroblast | 5 studies | 21% ± 4% | |
GABAergic neuron | 4 studies | 33% ± 14% | |
astrocyte | 4 studies | 40% ± 20% | |
glutamatergic neuron | 4 studies | 43% ± 17% | |
oligodendrocyte precursor cell | 4 studies | 26% ± 6% | |
oligodendrocyte | 4 studies | 28% ± 17% | |
dendritic cell | 3 studies | 19% ± 1% | |
epithelial cell | 3 studies | 27% ± 10% | |
alveolar macrophage | 3 studies | 22% ± 7% | |
endothelial cell of lymphatic vessel | 3 studies | 23% ± 0% | |
natural killer cell | 3 studies | 19% ± 1% | |
type I pneumocyte | 3 studies | 20% ± 5% | |
lymphocyte | 3 studies | 26% ± 8% | |
transit amplifying cell | 3 studies | 47% ± 29% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 350.42 | 1445 / 1445 | 100% | 10.80 | 183 / 183 |
prostate | 100% | 1734.22 | 245 / 245 | 100% | 36.08 | 502 / 502 |
breast | 100% | 390.49 | 459 / 459 | 100% | 10.83 | 1116 / 1118 |
uterus | 100% | 524.38 | 170 / 170 | 100% | 14.70 | 458 / 459 |
ovary | 100% | 389.86 | 180 / 180 | 100% | 11.04 | 429 / 430 |
bladder | 100% | 479.62 | 21 / 21 | 100% | 10.54 | 502 / 504 |
stomach | 100% | 281.15 | 359 / 359 | 99% | 9.45 | 283 / 286 |
lung | 99% | 307.38 | 572 / 578 | 100% | 10.48 | 1154 / 1155 |
intestine | 100% | 451.60 | 966 / 966 | 99% | 9.52 | 521 / 527 |
skin | 100% | 930.69 | 1809 / 1809 | 98% | 9.23 | 464 / 472 |
thymus | 100% | 299.42 | 653 / 653 | 96% | 5.22 | 578 / 605 |
pancreas | 98% | 181.15 | 321 / 328 | 96% | 5.36 | 170 / 178 |
brain | 95% | 145.52 | 2522 / 2642 | 95% | 5.21 | 670 / 705 |
kidney | 98% | 208.97 | 87 / 89 | 92% | 4.47 | 828 / 901 |
liver | 97% | 139.36 | 219 / 226 | 83% | 4.23 | 338 / 406 |
adrenal gland | 98% | 255.09 | 252 / 258 | 74% | 2.74 | 171 / 230 |
adipose | 100% | 380.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.29 | 29 / 29 |
spleen | 100% | 465.14 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.37 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.37 | 1 / 1 |
blood vessel | 100% | 365.39 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 519.20 | 891 / 929 | 0% | 0 | 0 / 0 |
heart | 94% | 168.68 | 809 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 4.64 | 72 / 80 |
muscle | 90% | 125.72 | 720 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1903934 | Biological process | positive regulation of DNA primase activity |
GO_0006270 | Biological process | DNA replication initiation |
GO_0006269 | Biological process | DNA replication, synthesis of primer |
GO_1990077 | Cellular component | primosome complex |
GO_0005658 | Cellular component | alpha DNA polymerase:primase complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0003677 | Molecular function | DNA binding |
GO_0071667 | Molecular function | DNA/RNA hybrid binding |
GO_0005515 | Molecular function | protein binding |
GO_0051539 | Molecular function | 4 iron, 4 sulfur cluster binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | PRIM2 |
Protein name | DNA primase large subunit DNA primase large subunit (DNA primase 58 kDa subunit) (p58) Primase DNA polypeptide 2 DNA primase subunit 2 |
Synonyms | PRIM2A |
Description | FUNCTION: Regulatory subunit of the DNA primase complex and component of the DNA polymerase alpha complex (also known as the alpha DNA polymerase-primase complex) which play an essential role in the initiation of DNA synthesis . During the S phase of the cell cycle, the DNA polymerase alpha complex (composed of a catalytic subunit POLA1, an accessory subunit POLA2 and two primase subunits, the catalytic subunit PRIM1 and the regulatory subunit PRIM2) is recruited to DNA at the replicative forks via direct interactions with MCM10 and WDHD1 (By similarity). The primase subunit of the polymerase alpha complex initiates DNA synthesis by oligomerising short RNA primers on both leading and lagging strands . These primers are initially extended by the polymerase alpha catalytic subunit and subsequently transferred to polymerase delta and polymerase epsilon for processive synthesis on the lagging and leading strand, respectively (By similarity). In the primase complex, both subunits are necessary for the initial di-nucleotide formation, but the extension of the primer depends only on the catalytic subunit . Binds RNA:DNA duplex and coordinates the catalytic activities of PRIM1 and POLA2 during primase-to-polymerase switch. . |
Accessions | ENST00000671770.1 A0A5F9ZHR0 ENST00000615550.5 [P49643-1] I0CMJ8 P49643 I0EZ64 ENST00000672107.1 H9XFA6 A0A096LP51 A0A5F9ZHU7 ENST00000370687.6 [P49643-2] I0CMK6 ENST00000274891.10 [P49643-2] ENST00000550475.2 H9XFA7 |